Ces Urol 2006, 10(1):27-31 | DOI: 10.48095/cccu2006007

Upper urinary tract function in patients suffering from multiple sclerosis

J. Krhut1, P. Hradílek2, K. Mainer1, O. Zapletalová2
1 Urologické oddělení FNsP Ostrava-Poruba
2 Neurologická klinika FNsP Ostrava-Poruba

Introduction: Multiple sclerosis (MS) is a systemic autoimmune disorder affecting the structures of the central nervous system (CNS). In a high proportion of cases it is also manifested by symptoms of lower urinary tract dysfunction (frequency, urgency, urgent incontinence, evacuation dysfunction). By contrast, impaired function of the upper urinary tract is reported rarely. Our aim was to analyse upper urinary tract function in our own cohort of MS patients.

Material and methods: The authors present an analysis of upper urinary tract function in a total of 148 multiple sclerosis patients (39 men, 109 women).
The mean duration of disease (period of time from the onset of persistent symptoms) was 12.6 (2-47) years. The mean value of the EDSS score (Expanded Disability Status Scale) expressing the degree of severity of disease was 4.47 (0-8.5) in our cohort. A total of 133 (89.9%) patients in our cohort reported symptoms of lower urinary tract dysfunction. The mean duration of the symptoms of lower urinary tract dysfunction was 7.19 (2-43) years.
Renal function assessment using serum creatinine clearance was performed in the patients in our cohort.

Results: The mean value of serum creatinine clearance in our cohort was 2.23ml/s/1.73 m2(0.776-8.5). Values below the lower limit of normal were recorded in 4 (3.01%) patients in our cohort. We correlated the value of creatinine clearance with the duration of symptoms, the time from diagnosis of multiple sclerosis, the duration of lower urinary tract symptoms, and the stage of disease as expressed by the EDSS score. No statistical dependence was found in any of these cases.

Conclusion: The results obtained show that while lower urinary tract dysfunctions in MS patients are very common and are among the principal symptoms of the disease, impaired function of the upper urinary tract is very rare.

Keywords: upper urinary tract function, multiple sclerosis, creatinine clearance, lower urinary tract dysfunction

Published: January 1, 2006 


References

  1. Ford HL, Gerry E, Johnson M, Williams R. A prospective study of the incidence, prevalence and mortality of multiple sclerosis in Leeds. J Neurol 2002; 249 (3): 260. Go to original source... Go to PubMed...
  2. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444. Go to original source... Go to PubMed...
  3. Andersen JT, Bradley WE. Abnormalities of detrusor and sphincter function in multiple sclerosis. R J Urol 1976; 48: 193. Go to original source... Go to PubMed...
  4. Ivers RR, Goldstein NP. Multiple sclerosis: a current appraisal of symptoms and signs. Proc Mayo Clin 1963; 38: 457.
  5. Miller H, Simpson CA, Yeates WK. Bladder dysfunction in multiple sclerosis. BMJ 1965; 1: 1265. Go to original source... Go to PubMed...
  6. Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol 1999;(3): 743. Go to original source... Go to PubMed...
  7. Hanuš T. Neurogenní příčiny inkontinence moče. Soc péče 2001; 2: 5.
  8. Zámečník L, Novák K, Hanuš T, Nováková I, Havrdová E. Urologické obtíže u roztroušené sklerózy - diagnostika a terapie. Urologie - referátový výběr 1998; 20: 242.
  9. Kasabian NG, Krause I, Brown WE, Khan Z, Nagler HM. Fate of the upper urinary tract in multiple sclerosis. Neurourol Urodyn 1995; 14 (1): 81. Go to original source... Go to PubMed...
  10. Porru D, Campus G, Garau A, Sorgia M, Pau AC, Spinici G et al. Urinary tract dysfunction in multiple sclerosis: is there a relation with disease-related parameters? Spinal Cord 1997; 35 (1): 33. Go to original source... Go to PubMed...
  11. Sliwa JA, Bell HK, Mason KD, Gore RM, Nanninga J, Cohen B. Upper urinary tract abnormalities in multiple sclerosis patients with urinary symptoms. Arch Phys Med Rehabil 1996; 77 (3): 247. Go to original source... Go to PubMed...
  12. Vora JP, Burch A, Owens DR, Peters JR. Simultaneous determination of glomerular filtration rate and effective renal plasma flow. Clin Phys Physiol Meas 1991; 12 (3): 269. Go to original source... Go to PubMed...
  13. Tobias GJ, Mc Laughlin RF Jr, Hopper J Jr. Endogenous creatinine clearance. A valuable clinical test of glomerular filtration and a prognostic guide in chronic renal disease. N Engl J Med 1962; 266: 317. Go to original source... Go to PubMed...
  14. Hintze J. NCSS and PASS, Number Crundur Statistical Systems, Kaysville, Utah, US
  15. www.NCSS.com.
  16. Zachoval R, Piťha J, Medová E. Augmentation cystoplasty in patients with multiple sclerosis. Urologia Internationalis 2003; 70: 21. Go to original source... Go to PubMed...
  17. Zachoval R, Lukeš M, Heráček J. Urologická problematika pacientů s roztroušenou sklerózou. Praktický lékař 2002; 82: 319.
  18. Jameson RM. Management of the bladder in non-traumatic paraplegia. Paraplegia 1975; 12: 92. Go to original source... Go to PubMed...
  19. Weld KJ, Wall BM, Mangold TA, Steere EL, Dmochowski RR. Influences on renal function in chronic spinal cord injured patients. J Urol 2000; 164 (5): 1490. Go to original source... Go to PubMed...
  20. Schoenberg HW, Gutrich J, Banno J. Urodynamics patterns in multiple sclerosis. J Urol 1979; 122: 648. Go to original source... Go to PubMed...
  21. Gonor SE, Caroll DJ, Metcalf JB. Vesical dysfunction in multiple sclerosis. Urology 1985; 25: 429. Go to original source... Go to PubMed...
  22. Blaivas JG. Management of bladder dysfunction in multiple sclerosis. Neurology 1980; 30: 12. Go to original source... Go to PubMed...
  23. Barbalias GA, Nikiforidis G, Liatsikos EN. Vesicourethral dysfunction associated with multiple sclerosis: clinical and urodynamic perspectives. J Urol 1998; 160 (1): 106. Go to original source... Go to PubMed...
  24. Zámečník L, Novák K. Sfinkterové poruchy u RS, diagnostika a terapie. Občasník Společnosti pro výzkum a terapii roztroušené sklerózy mozkomíšní, likvorologii a neuroimunologii. 1997 6: 6.
  25. VanPoppel H, Vereecken RL, Leruitte A. Neuromuscular dysfunction of the lower urinary tract in multiple sclerosis. Paraplegia 1983; 21: 374. Go to original source... Go to PubMed...
  26. Amarenco G, Kerdraon J, Denys P. Bladder and sphincter disorders in multiple sclerosis. Clinical, urodynamic and neurophysiological study of 225 cases. Rev Neurol 1995;(12): 722.
  27. Zámečník L, Novák K, Soukup V, Havrdová E, Nováková I, Horáková D. Vývoj dysfunkce dolních močových cest u remitentní formy roztroušené sklerózy v závislosti na typu neurologické léčby - průběžné výsledky. Urológia 2004; 10: 37.
  28. Fowler CJ, van Kerrebroeck PE, Nordenbo A, Van Poppel H. Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1992;(11): 986. Go to original source...





Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.



Odejít Vstoupit